Systemic Juvenile Idiopathic Arthritis
The DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
Abstract
Systemic juvenile idiopathic arthritis (sJIA) is a distinctive subtype of juvenile idiopathic arthritis, characterized by fever and arthritis, often accompanied by rash, sometimes by generalized lymphadenopathy, hepatosplenomegaly, and serositis. The diagnosis requires adequate exclusion of infectious, oncologic, autoimmune, and autoinflammatory diseases. Macrophage activation syndrome, a serious and potentially fatal complication of sJIA, requires prompt evaluation and treatment. Newer biologic agents, particularly interleukin-1 and interleukin-6 inhibitors, are highly effective and have transformed the treatment approach by reducing the use of systemic glucocorticoids. Primary care providers have a crucial role in monitoring children with sJIA for disease-related complications and medication-related adverse events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–214 of 214
Current treatments for juvenile idiopathic arthritis
Quartier, P. (2010) · Joint Bone Spine · doi:10.1016/j.jbspin.2010.09.002 · Cited by 33
Wang, Z., Wang, Y., Wang, J., Feng, C., Tian, L., & Wu, L. (2009) · International Journal of Hematology · doi:10.1007/s12185-009-0391-5 · Cited by 28
Correlates of Disablement in Systemic Onset Juvenile Chronic Arthritis
van der Net, J. J., Kuis, W., Prakken, A. B. J., Lukkassen, I., Sinnema, G., Hutter, A. P., Brackel, H., de Wilde, E. J., & Helders, P. J. M. (1997) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749709065680 · Cited by 27
Ramanan, A. V., Rosenblum, N. D., Feldman, B. M., et al. (2004) · PubMed · Cited by 24
Microcytic anaemia in juvenile chronic arthritis.
Harvey, A. R., Mj, P., & Bm, A. (1987) · PubMed · Cited by 20
Ravelli, A., Schneider, R., Weitzman, S. S., Devlin, C. E., Daimaru, K., Yokota, S., Takei, S., & Benedetti, F. D. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38472 · Cited by 20
Self-citationCantarini, L., Lucherini, O. M., Cimaz, R., Rigante, D., Baldari, C. T., Pasini, F. L., & Galeazzi, M. (2010) · Rheumatology International · doi:10.1007/s00296-010-1512-4 · Cited by 17
Ling, X. B., Macaubas, C., Alexander, H. C., Wen, Q., Chen, E., Peng, S., Sun, Y., Deshpande, C., Pan, K., Lin, R., et al. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-125 · Cited by 13
Zeft, A., Menon, S. C., & Miller, D. V. (2012) · Pediatric Rheumatology · doi:10.1186/1546-0096-10-8 · Cited by 13
Cifaldi, L., Prencipe, G., Caiello, I., Bracaglia, C., Strippoli, R., & Benedetti, F. D. (2014) · Pediatric Rheumatology · doi:10.1186/1546-0096-12-s1-p56 · Cited by 7
Chapter 3 Systemic Juvenile Idiopathic Arthritis
Schneider, R., & Laxer, R. M. (2007) · Technical report · doi:10.1016/s1571-5078(07)06007-2 · Cited by 5
Self-citationGiraldo, W. A. S., Moratilla, A. B., Caparrós, A. M., & Gámir, M. L. G. (2014) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2013.09.001 · Cited by 4
Giraldo, W. A. S., Moratilla, A. B., Caparrós, A. M., & Gámir, M. L. G. (2013) · Reumatología Clínica · doi:10.1016/j.reuma.2013.09.001 · Cited by 3
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Cited by
Juvenile Idiopathic Arthritis: Will Etanercept be an Improvement over Current Therapies?
De Benedetti, F., & Ravelli, A. (2000) · BioDrugs · doi:10.2165/00063030-200014020-00003 · Cited by 428
Martini, A., Lovell, D. J., Albani, S., Brunner, H. I., Hyrich, K. L., Thompson, S. D., & Ruperto, N. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00332-8 · Cited by 289
Avau, A., Mitera, T., Put, S., Put, K., Brisse, E., Filtjens, J., Uyttenhove, C., Van Snick, J., Liston, A., Leclercq, G., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38359 · Cited by 90
Metadata
- Authors
- Lee, J. J. Y., & Schneider, R.
- Venue
- Pediatric Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 65
- Issue
- 4
- Pages
- 691-709
- ISSN
- 0031-3955 (ISSN-L)
- OpenAlex
- W2501949584
- Cited by
- 166
- References
- 214
- FWCI
- 8.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.